The manufacturing facilities of Cadila Pharmaceuticals conform to the most stringent international cGMP norms viz., WHO-GMP, WHO-Geneva (GDF site for Anti-TB), USFDA, TGA Australia (PIC/S), MHRA-UK, MCC-South Africa, ISO 9001 and ISO 14001
Dholka, Gujarat, India
Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations plat at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the-art facility is not only impressive in size, but is also USFDA approved.
Samba, Jammu, India
The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatine capsules, liquids and orals.
Ankleshwar, Gujarat, India
Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture more than 50 APIs and intermediates including many USFDA-certified products.
Addis Ababa, Ethiopia
The company has also set up its first ever overseas formulation manufacturing facility at Addis Ababa in Ethiopia which is the only WHO-cGMP compliant manufacturing facility in the region.